Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS: NYMXF · Delayed Price · USD
0.350
+0.025 (7.63%)
Apr 30, 2024, 4:00 PM EDT - Market closed
Nymox Pharmaceutical Statistics
Total Valuation
NYMXF has a market cap or net worth of $27.98 million. The enterprise value is $27.74 million.
Market Cap | 27.98M |
Enterprise Value | 27.74M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 42.05% |
Owned by Institutions (%) | 0.05% |
Float | 53.09M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.19
Current Ratio | 0.19 |
Quick Ratio | 0.15 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -86.18 |
Financial Efficiency
Return on equity (ROE) is -1,589.50%.
Return on Equity (ROE) | -1,589.50% |
Return on Assets (ROA) | -117.20% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.46% in the last 52 weeks. The beta is 0.32, so NYMXF's price volatility has been lower than the market average.
Beta (1Y) | 0.32 |
52-Week Price Change | -5.46% |
50-Day Moving Average | 0.37 |
200-Day Moving Average | 0.62 |
Relative Strength Index (RSI) | 51.53 |
Average Volume (30 Days) | n/a |
Short Selling Information
Short Interest | 2.03M |
Short Previous Month | 2.08M |
Short % of Shares Out | n/a |
Short % of Float | 3.83% |
Short Ratio (days to cover) | 59.74 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -2.96M |
Pretax Income | -2.88M |
Net Income | -2.88M |
EBITDA | -2.60M |
EBIT | -2.84M |
Earnings Per Share (EPS) | -$0.04 |
Balance Sheet
The company has $351,000 in cash and $114,000 in debt, giving a net cash position of $237,000.
Cash & Cash Equivalents | 351,000 |
Total Debt | 114,000 |
Net Cash | 237,000 |
Net Cash Per Share | n/a |
Equity / Book Value | -1.80M |
Book Value Per Share | n/a |
Working Capital | -1.91M |
Cash Flow
In the last 12 months, operating cash flow was -$1.99 million and capital expenditures -$3,000, giving a free cash flow of -$1.99 million.
Operating Cash Flow | -1.99M |
Capital Expenditures | -3,000 |
Free Cash Flow | -1.99M |
FCF Per Share | -$0.02 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NYMXF does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -5.22% |
Shareholder Yield | -5.22% |
Earnings Yield | -10.28% |
FCF Yield | -7.11% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |